PSY32 THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74875-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)74875-0/fulltext
Title :
PSY32 THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74875-0&doi=10.1016/S1098-3015(10)74875-0
First page :
Section Title :
Open access? :
No
Section Order :
802